MNKD Stock: Price, Earnings History and SEC Filings
MannKind Corporation (MNKD) last traded at $3.50, up 0.00% on the latest session and down 10.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.06 against an analyst estimate of $-0.02, a miss of 200.0%.
$3.50 +0.00%
1 month-10.26%
52-week high$6.51
52-week low$2.23
Volume2.01M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
MNKD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.06 | $-0.02 | -200.00% |
| Mar 2026 | May 6, 2026 | $-0.05 | $-0.02 | -150.00% |
| Dec 2025 | Feb 26, 2026 | $-0.05 | $-0.01 | -400.00% |
| Sep 2025 | Nov 5, 2025 | $0.03 | $0.01 | +200.00% |
MNKD beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for MNKD
SEC filing data is not available right now. You can search for MNKD on SEC EDGAR.
MNKD news
- Can MannKind (MNKD) Still Be A Bargain On Cash Flow?Nov 1, 2026 · finance.yahoo.com
- MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026Oct 29, 2026 · finance.yahoo.com
- MannKind Advances Inhaled IPF Drug to Global Phase 2, Eyes FUROSCIX GrowthOct 20, 2026 · marketbeat.com
- Learn Why The Bull Case For MannKind Stock Could Change Following Outpatient Diuretic DataOct 20, 2026 · finance.yahoo.com
About MannKind Corporation
MannKind Corporation (MNKD) is a US-listed public company on Nasdaq.